Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated OCI	Total
Balance at the beginning at Dec. 31, 2021	$ 17	$ 568,183	$ (9,535)		$ 558,665
Balance at the beginning (in shares) at Dec. 31, 2021	167,557,988
Changes in stockholder's equity
Net loss			(10,344)		(10,344)
Transaction fees		(12)			(12)
Stock options exercised		270			270
Stock options exercised (in shares)	6,212,964
Stock-based compensation expense		1,596			1,596
Unrealized loss on marketable securities				$ (330)	(330)
Balance at the end at Mar. 31, 2022	$ 17	570,037	(19,879)	(330)	549,845
Balance at the end (in shares) at Mar. 31, 2022	173,770,952
Balance at the beginning at Dec. 31, 2021	$ 17	568,183	(9,535)		558,665
Balance at the beginning (in shares) at Dec. 31, 2021	167,557,988
Changes in stockholder's equity
Net loss					3,321
Shares issued for the vesting of RSUs (in shares)	20,672
Stock options exercised (in shares)	6,869,144
Balance at the end at Jun. 30, 2022	$ 17	572,456	(6,212)	(1,291)	564,970
Balance at the end (in shares) at Jun. 30, 2022	174,447,804
Balance at the beginning at Mar. 31, 2022	$ 17	570,037	(19,879)	(330)	549,845
Balance at the beginning (in shares) at Mar. 31, 2022	173,770,952
Changes in stockholder's equity
Net loss			13,667		13,667
Withholding of employee taxes related to stock-based compensation		(58)			(58)
Shares issued for the vesting of RSUs (in shares)	20,672
Stock options exercised		163			163
Stock options exercised (in shares)	656,180
Stock-based compensation expense		2,314			2,314
Unrealized loss on marketable securities				(961)	(961)
Balance at the end at Jun. 30, 2022	$ 17	572,456	(6,212)	(1,291)	564,970
Balance at the end (in shares) at Jun. 30, 2022	174,447,804
Balance at the beginning at Dec. 31, 2022	$ 18	577,603	(19,090)	(3,159)	555,372
Balance at the beginning (in shares) at Dec. 31, 2022	176,007,184
Changes in stockholder's equity
Net loss			(19,158)		(19,158)
Stock options exercised		150			150
Stock options exercised (in shares)	1,679,954
Stock-based compensation expense		2,222			2,222
Unrealized loss on marketable securities				885	885
Balance at the end at Mar. 31, 2023	$ 18	579,975	(38,248)	(2,274)	539,471
Balance at the end (in shares) at Mar. 31, 2023	177,687,138
Balance at the beginning at Dec. 31, 2022	$ 18	577,603	(19,090)	(3,159)	555,372
Balance at the beginning (in shares) at Dec. 31, 2022	176,007,184
Changes in stockholder's equity
Net loss					(31,365)
Shares issued under ESPP (in shares)	129,928
Shares issued for the vesting of RSUs (in shares)	163,148
Stock options exercised (in shares)	2,026,630
Balance at the end at Jun. 30, 2023	$ 18	583,034	(50,369)	(3,372)	529,311
Balance at the end (in shares) at Jun. 30, 2023	178,326,890
Balance at the beginning at Mar. 31, 2023	$ 18	579,975	(38,248)	(2,274)	539,471
Balance at the beginning (in shares) at Mar. 31, 2023	177,687,138
Changes in stockholder's equity
Net loss			(12,205)		(12,205)
Shares issued under ESPP		214			214
Shares issued under ESPP (in shares)	129,928
Withholding of employee taxes related to stock-based compensation		(111)	84		(27)
Shares issued for the vesting of RSUs (in shares)	163,148
Stock options exercised		33			33
Stock options exercised (in shares)	346,676
Stock-based compensation expense		2,923			2,923
Unrealized loss on marketable securities				(1,098)	(1,098)
Balance at the end at Jun. 30, 2023	$ 18	$ 583,034	$ (50,369)	$ (3,372)	$ 529,311
Balance at the end (in shares) at Jun. 30, 2023	178,326,890